INBS Stock Risk & Deep Value Analysis
Intelligent Bio Solutions Inc
Healthcare • Medical Devices
DVR Score
out of 10
What You Need to Know About INBS Stock
We analyzed Intelligent Bio Solutions Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran INBS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
How Risky Is INBS Stock?
Overall Risk
Aggressive
Financial Risk
High
Market Risk
Medium
Competitive Risk
High
Execution Risk
High
Regulatory Risk
High
What Are the Red Flags for INBS?
- ⚠
Regulatory rejections or prolonged delays
- ⚠
Failure to secure adequate funding for operations
- ⚠
Intensified competition from alternative screening methods
- ⚠
Lower-than-expected Q4 2025 financial results
Unlock INBS Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Intelligent Bio Solutions Inc (INBS) Do?
Market Cap
$9.14M
Sector
Healthcare
Industry
Medical Devices
Employees
53
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Visit Intelligent Bio Solutions Inc WebsiteIs INBS Stock Undervalued?
Unlock the full AI analysis for INBS
Get the complete DVR score, risk analysis, and more
Does INBS Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Stable
Moat Sources
1 Identified
The moat is primarily derived from its patented non-invasive fingerprint technology. Its durability is contingent upon successful commercialization, continued patent defense, and the ability to build network effects or switching costs through widespread adoption, which is currently unproven.
Moat Erosion Risks
- •Patent challenges or expiration exposing technology
- •Competitors developing alternative non-invasive methods
- •Regulatory changes favoring other screening techniques
INBS Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive INBS Stock Higher?
Near-Term (0-6 months)
- •Q4 2025 Earnings Report (Estimated early-March 2026)
- •Updates on regulatory submissions for core technology
- •Announcements of new pilot programs or small commercial contracts
Medium-Term (6-18 months)
- •Major regulatory approval for key markets (e.g., FDA clearance)
- •Significant commercial partnership or distribution agreement
- •Expansion into new geographic markets (e.g., Europe, APAC)
Long-Term (18+ months)
- •Widespread adoption of non-invasive drug screening as industry standard
- •Potential acquisition by a larger diagnostics company
- •Technological advancements extending platform capabilities
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for INBS?
- ✓
Clear regulatory approval announcements (e.g., FDA)
- ✓
Major commercial contracts or significant revenue acceleration
- ✓
Improved cash burn rate and successful financing rounds
Bull Case Analysis
See what could go right with Premium
Compare INBS to Similar Stocks
See how Intelligent Bio Solutions Inc stacks up against related companies in our head-to-head analysis.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for INBS (Intelligent Bio Solutions Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
